KLEMP WALTER V
CEO and President
KLEMP WALTER V has filed 5 SEC Form 4 filings (10 transaction rows) across 2 companies, including MBRX, AMIX, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Oct 17, 2026.
On the most recent filing, KLEMP WALTER V is listed as CEO and President at Moleculin Biotech, Inc. Inside the rolling window, KLEMP WALTER V reported 1 open-market purchase in MBRX and no open-market sales.
Companies traded
Other insiders at MBRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has KLEMP WALTER V made?
KLEMP WALTER V has filed 5 SEC Form 4 filings (10 transaction rows) across 2 companies, including MBRX, AMIX since 2025.
Which companies does KLEMP WALTER V trade?
KLEMP WALTER V has filed SEC Form 4 disclosures for 2 companies, including MBRX, AMIX.
When was KLEMP WALTER V's most recent SEC Form 4 filing?
KLEMP WALTER V's most recent SEC Form 4 filing on Tracefour is dated Oct 17, 2026.
What is KLEMP WALTER V's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, KLEMP WALTER V is listed as CEO and President.